drugset / Trial / NCT01096134

Mother - Daughter Initiative (MDI) in Cervical Cancer Prevention

NCT01096134

Completed 8000 enrolled Jhpiego Merck Sharp & Dohme LLC · collab
NaSingle-groupOpen-labelPrevention

Summary

The Mother-Daughter Initiative (MDI) will test the feasibility and acceptability of a strategy to deliver comprehensive cervical cancer prevention services in Thailand and the Philippines by integrating the HPV vaccine for girls ages 9-13 into already successful screening and treatment programs for mothers.

Timeline

Start
2011-01
Primary completion
2012-11
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Gardasil Vaccine 0.5 ml Intramuscular

Indications